The increasing complexity of cancer treatment necessitates a comprehensive understanding of varied healthcare models. This article aims to explore the benefits and limitations of transatlantic cancer care, contrasting the clinical pathways in both the United States and other regions. Through a holistic lens, we will assess key factors, including tr